Cathepsin B Is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug Candidate

Frontiers in Neurology - Switzerland
doi 10.3389/fneur.2015.00178
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Frontiers Media SA

Related search

Endocannabinoids: A Promising Impact for Traumatic Brain Injury

Frontiers in Pharmacology
Pharmacology
2017English

Traumatic Brain Injury in Drug Users

Sudebno-Meditsinskaya Ekspertisa
MedicineAnatomyPathologyForensic Medicine
2020English

MicroRNA Let-7i Is a Promising Serum Biomarker for Blast-Induced Traumatic Brain Injury

Journal of Neurotrauma
Neurology
2012English

Myeloperoxidase: A Target for New Drug Development?

British Journal of Pharmacology
Pharmacology
2007English

Nuclear Peroxiredoxine: A Promising Target for Drug & Diagnostic Solutions of Malaria

Journal of Bacteriology & Mycology: Open Access
2016English

Mining a Cathepsin Inhibitor Library for New Antiparasitic Drug Leads

PLoS Neglected Tropical Diseases
PharmacologyPublic HealthEnvironmentalToxicologyInfectious DiseasesPharmaceuticsOccupational Health
2011English

Microglia Activation as a Biomarker for Traumatic Brain Injury

Frontiers in Neurology
Neurology
2013English

Choline Kinase Emerges as a Promising Drug Target in Gram-Positive Bacteria

Frontiers in Microbiology
Microbiology
2019English

Identification of Cephalomannine as a Drug Candidate for Glioblastoma via High-Throughput Drug Screening

Journal of Electrophoresis
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy